• US Defence Agencies Grapple With Gene Drives

    Nature News & Comment | National security community examines the risks and benefits of technology to quickly spread genetic modifications.

    Jul 21, 2017
  • Supercomputer Maker Cray Cutting 14% Of workforce, 190 Jobs, Seeking To Save $25M Per Year

    GeekWire | Seattle supercomputer maker Cray plans to cut 190 jobs, representing about 14% of its global workforce, as part of a restructuring plan meant to cut costs.

    Jul 20, 2017
  • Certified Public Accountants Launch Framework For Cybersecurity Audits

    Bio-IT World Contributed Commentary | Cybercriminals are stealing healthcare data by targeting vendors and third parties, both of which often have weaker security in place. In May 2017, The American Institute of CPAs released their Cybersecurity Attestation Framework. Also known as Service Organization Control for cybersecurity, this framework builds on top of the long-established Trust Services Principles reporting.

    Jul 20, 2017
  • Novogene And Pacific Biosciences To Develop And Co-Market Applications Based On Sequel Platform

    Bio-IT World Brief | Novogene and Pacific Biosciences of California have agreed to jointly develop and promote novel applications based on the PacBio Sequel System. New applications developed under this agreement are expected to focus on basic and translational research in the field of precision medicine, including methods for sample processing, workflow automation, algorithm development, and database construction.

    Jul 18, 2017
  • Big Pharma Buys Into Crowdsourcing For Drug Discovery

    WIRED | The Structural Genomics Consortium encourages pharma companies and academics to put all their cards on the table in the interest of speeding up drug research.

    Jul 17, 2017
  • Illumina Announces Nuerodegeneration Panel

    Bio-IT World News Brief  Illumina has announced the TruSeq Neurodegeneration Panel, which targets 118 genes selected with input from a group of 16 leading neurodegenerative researchers and includes broad coverage of diseases such as Alzheimer’s, Parkinson’s, Amyotrophic Lateral Sclerosis (ALS), and other neurodegenerative disorders.

    Jul 14, 2017
  • Novartis CAR-T Gets FDA Panel Nod But The Class Has More Hurdles

    Bloomberg.com | Novartis wins over an FDA panel, but the road to commercial viability is long.

    Jul 14, 2017
  • Industry Standards Group, Align Biopharma, Expands To 23 Members

    Bio-IT World Brief | Align Biopharma today introduced 14 leading biopharma companies and technology and service providers as new members. The group now includes a total of 23 members dedicated to making it easier for healthcare professionals to connect digitally with life sciences companies.

    Jul 13, 2017
  • NCBI Facilitates Hackathons at the Bio-IT World Conference and Silicon Valley Artificial Intelligence

    NCBI Insights | NCBI usually participates in hackathons as direct organizers and planners. However, NCBI staff recently functioned as facilitators in two hackathons organized by outside groups: one at the Bio-IT World conference, and one at the Silicon Valley Artificial Intelligence (SVAI) incubator.

    Jul 12, 2017
  • One Mans Plan to Make Sure Gene Editing Doesnt Go Haywire

    The Atlantic | Kevin Esvelt argues that the tremendous power of CRISPR can only be contained if scientists are open about their research.

    Jul 12, 2017
  • Experimental Drug Reversed Memory Loss In Mice With Possible Implications For Calico

    San Francisco Business Times | UCSF researchers found that the experimental drug helped restore the ability of brain-injured mice to form new memories. It would be years away from use in humans but could offer hope to people with Alzheimer's and other brain diseases.

    Jul 11, 2017
  • White House’s Dwindling Science Office Leaves Major Research Programs In Limbo

    Nature News & Comment | Pared-back staff struggles to continue cybersecurity, climate-change, and science-education efforts without direction from the Trump administration.

    Jul 11, 2017
  • Thermo Fisher Scientific And SRI International Collaborate To Enhance Small Molecule Research

    Bio-IT World Brief | Thermo Fisher Scientific and SRI International today announced the results of a collaboration agreement to enable researchers to combine the results of high-resolution Orbitrap LC/MS experiments with highly curated and organism-specific metabolic pathway and genome data for quick and effective mass spectrometry-based small molecule research and analysis.

    Jul 10, 2017
  • 10 Years Of GWAS Discovery: Biology, Function, And Translation

    Bio-IT World Brief | Application of the experimental design of genome-wide association studies is now 10 years old, and researchers now review the remarkable range of discoveries it has facilitated in population and complex-trait genetics, the biology of diseases, and translation toward new therapeutics.

    Jul 7, 2017
  • Ancient-Genome Studies Grapple With Africa’s Past

    Nature News & Comment | Ignored for too long by researchers, ancient humans who lived in Africa thousands of years ago are finally having their genomes studied. Two projects released results this week on the genomes of around 20 individuals, which together reveal that the history of our species on the continent was far more complex than previously thought.

    Jul 6, 2017
  • Encouraging Inclusion In Supercomputing

    Bio-IT World | Several programs and groups are being created to address the issue of improving and optimizing the inclusion of women in the field of supercomputing.

    Jul 6, 2017
  • How To Build A Human Cell Atlas

    Nature News & Comment | Aviv Regev is a maven of hard-core biological analyses. Now she is part of an effort to map every cell in the human body.

    Jul 5, 2017
  • Illumina Announces Companion Diagnostic For Amgen Colorectal Cancer Drug

    Diagnostics World News | Illumina has announced FDA approval of its Extended RAS Panel for use on the MiSeqDx System. The next-generation sequencing kit is intended to help clinicians identify which patients are eligible for treatment of metastatic colorectal cancer with Amgen's Vectibix.

    Jun 30, 2017
  • Best Practices For Adopting An Enterprise Screening Platform

    Bio-IT World Contributed Commentary | A few years back, AstraZeneca started on a journey to adopt and implement an enterprise-level screening platform for use company-wide. Here are some of the important milestones in that journey.

    Jun 30, 2017
  • The Jackson Laboratory, Illumina, Sinequa, And More: News From June 2017

    Bio-IT World Brief | News, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including The Jackson Laboratory, Illumina, Sinequa, and more.

    Jun 29, 2017